Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Johnson & Johnson with a target price of $175. An analyst from HSBC upgraded its action to Buy with a price ...
John Johnson of Westlake was the epitome of health, eating the right foods and staying active, completing the 2023 Cleveland ...
Los Angeles Lakers legend Magic Johnson posted on social media Tuesday that the San Antonio Spurs would "definitely be a ...
14d
Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales ...
The Senate passed a $95 billion aid bill for Ukraine, Israel and Taiwan in February but Johnson has refused to take up the legislation and is not expected to do so. It's not clear when and if ...
The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures ...
“It can happen again,” Chutkan, who is expected to preside over Donald Trump ... after the latter pushed to vacate Speaker Mike Johnson over his surprising Ukraine reversal, now faces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback